Skip to main content
. 2022 Nov 25;12(12):1754. doi: 10.3390/biom12121754

Figure 2.

Figure 2

e-Drug3D-lib docking summary. Surface representation of Mpro complexed with (a,b) Ciclesonide, (c,d) Losartan and (e,f) Telmisartan resulting from site-specific and blind docking studies, respectively. The corresponding LigPlot interaction maps (polar residue names in blue font and non-polar residue names in brown font) are shown adjacent to the complexes.